Title Lymphoid leukaemia
Type Stage Two
Code HLS165
Requirement Compulsory

Module objective

By the end of the training period trainees will, in respect of lymphoid leukaemia, be able to:

  • analyse, synthesise, evaluate and apply knowledge
  • perform, adapt and master a range of technical and clinical skills and procedures
  • demonstrate the attitudes and behaviours necessary for professional practice as a consultant clinical scientist dealing with the complexities, uncertainties and tensions of professional practice at this level.

Knowledge and understanding

By the end of the training period the trainee will be able to demonstrate the ability to analyse, evaluate and synthesise relevant knowledge and its application to their professional practice in relation to

  • acute lymphoblastic leukaemia, chronic lymphocytic leukaemia
  • epidemiology and pathophysiology of disease
  • laboratory and clinical phenotypic diagnosis and classification
  • cell surface marker analysis
  • B cell and T cell clonal disorders
  • cytogenetics and molecular genetics
  • minimal residual disease
  • clinical aspects: symptoms, presentation, treatment principles and strategies
  • disease staging
  • ethical aspects: informed consent, Human Tissue Act.

Technical and clinical skills

By the end of the training period the trainee will be able to demonstrate a critical understanding of current relevant research, theory and knowledge and its application to the performance, adaptation and mastery of the following technical procedures and laboratory skills:

  • knowledge and understanding of pathogenesis, genetics and clinical and laboratory aspects of acute and chronic lymphoid leukaemia
  • produce a fully interpretative clinical diagnostic laboratory report
  • understand clinical management of lymphoid leukaemia
  • knowledge and understanding of ethical aspects of diagnosis and sample collection/storage in haematological disorders.

Attitudes and behaviours

This module has no attitude and behaviours information.


Code Title Action
HLS1-2-2-20 Haematology (Haemato-Oncology) [v1] View